nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Infusion site reaction—Docetaxel—melanoma	0.021	0.0368	CcSEcCtD
Remifentanil—Cerebral infarction—Carmustine—melanoma	0.0155	0.0271	CcSEcCtD
Remifentanil—Rales—Bleomycin—melanoma	0.0141	0.0247	CcSEcCtD
Remifentanil—Cerebral ischaemia—Temozolomide—melanoma	0.0101	0.0177	CcSEcCtD
Remifentanil—Pethidine—GRIN2A—melanoma	0.00957	0.509	CrCbGaD
Remifentanil—Lymphopenia—Temozolomide—melanoma	0.00953	0.0167	CcSEcCtD
Remifentanil—Atrial flutter—Docetaxel—melanoma	0.00853	0.015	CcSEcCtD
Remifentanil—Atrial fibrillation—Vemurafenib—melanoma	0.00731	0.0128	CcSEcCtD
Remifentanil—Coagulopathy—Dactinomycin—melanoma	0.00693	0.0121	CcSEcCtD
Remifentanil—Lymphopenia—Docetaxel—melanoma	0.00634	0.0111	CcSEcCtD
Remifentanil—Coagulopathy—Temozolomide—melanoma	0.00626	0.011	CcSEcCtD
Remifentanil—Leukocytosis—Carmustine—melanoma	0.00537	0.00942	CcSEcCtD
Remifentanil—Urinary incontinence—Carmustine—melanoma	0.00487	0.00854	CcSEcCtD
Remifentanil—Heartburn—Docetaxel—melanoma	0.00471	0.00826	CcSEcCtD
Remifentanil—Urinary incontinence—Temozolomide—melanoma	0.00471	0.00826	CcSEcCtD
Remifentanil—Disorientation—Bleomycin—melanoma	0.00469	0.00823	CcSEcCtD
Remifentanil—Ileus—Docetaxel—melanoma	0.00458	0.00803	CcSEcCtD
Remifentanil—Cardiac disorder—Vemurafenib—melanoma	0.00445	0.0078	CcSEcCtD
Remifentanil—Angiopathy—Vemurafenib—melanoma	0.00435	0.00762	CcSEcCtD
Remifentanil—Mediastinal disorder—Vemurafenib—melanoma	0.00432	0.00757	CcSEcCtD
Remifentanil—Chills—Vemurafenib—melanoma	0.0043	0.00754	CcSEcCtD
Remifentanil—Pleural effusion—Docetaxel—melanoma	0.00423	0.00743	CcSEcCtD
Remifentanil—Erythema—Vemurafenib—melanoma	0.00417	0.00731	CcSEcCtD
Remifentanil—Myocardial ischaemia—Docetaxel—melanoma	0.00403	0.00707	CcSEcCtD
Remifentanil—Rhinorrhoea—Docetaxel—melanoma	0.004	0.00702	CcSEcCtD
Remifentanil—Amnesia—Carmustine—melanoma	0.0039	0.00684	CcSEcCtD
Remifentanil—Nasal congestion—Temozolomide—melanoma	0.00389	0.00681	CcSEcCtD
Remifentanil—Amnesia—Temozolomide—melanoma	0.00377	0.00661	CcSEcCtD
Remifentanil—Cough—Vemurafenib—melanoma	0.00364	0.00638	CcSEcCtD
Remifentanil—Bronchospasm—Bleomycin—melanoma	0.00357	0.00626	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00353	0.00618	CcSEcCtD
Remifentanil—Oliguria—Docetaxel—melanoma	0.00352	0.00617	CcSEcCtD
Remifentanil—Anaphylactic shock—Vemurafenib—melanoma	0.0034	0.00597	CcSEcCtD
Remifentanil—Dysphagia—Dactinomycin—melanoma	0.00338	0.00593	CcSEcCtD
Remifentanil—Alfentanil—ALB—melanoma	0.00336	0.178	CrCbGaD
Remifentanil—Nervous system disorder—Vemurafenib—melanoma	0.00334	0.00585	CcSEcCtD
Remifentanil—Hypokalaemia—Carmustine—melanoma	0.00333	0.00585	CcSEcCtD
Remifentanil—Skin disorder—Vemurafenib—melanoma	0.00331	0.0058	CcSEcCtD
Remifentanil—Pneumonia—Bleomycin—melanoma	0.00325	0.0057	CcSEcCtD
Remifentanil—Hypokalaemia—Temozolomide—melanoma	0.00322	0.00565	CcSEcCtD
Remifentanil—Alfentanil—ABCB1—melanoma	0.0032	0.17	CrCbGaD
Remifentanil—Hypotension—Vemurafenib—melanoma	0.00318	0.00558	CcSEcCtD
Remifentanil—Dysphagia—Carmustine—melanoma	0.00317	0.00555	CcSEcCtD
Remifentanil—Haematuria—Bleomycin—melanoma	0.00308	0.00541	CcSEcCtD
Remifentanil—Dysphagia—Temozolomide—melanoma	0.00306	0.00536	CcSEcCtD
Remifentanil—Pneumonia—Dactinomycin—melanoma	0.00303	0.00532	CcSEcCtD
Remifentanil—Bronchitis—Temozolomide—melanoma	0.00294	0.00516	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Vemurafenib—melanoma	0.00294	0.00515	CcSEcCtD
Remifentanil—Haemoglobin—Bleomycin—melanoma	0.00292	0.00512	CcSEcCtD
Remifentanil—Constipation—Vemurafenib—melanoma	0.00291	0.0051	CcSEcCtD
Remifentanil—Haemorrhage—Bleomycin—melanoma	0.0029	0.00509	CcSEcCtD
Remifentanil—Pulmonary oedema—Docetaxel—melanoma	0.00289	0.00506	CcSEcCtD
Remifentanil—Dysuria—Temozolomide—melanoma	0.00286	0.00502	CcSEcCtD
Remifentanil—Hyperglycaemia—Carmustine—melanoma	0.00286	0.00501	CcSEcCtD
Remifentanil—Pneumonia—Carmustine—melanoma	0.00284	0.00498	CcSEcCtD
Remifentanil—Renal failure—Carmustine—melanoma	0.00277	0.00487	CcSEcCtD
Remifentanil—Hyperglycaemia—Temozolomide—melanoma	0.00276	0.00484	CcSEcCtD
Remifentanil—Pneumonia—Temozolomide—melanoma	0.00274	0.00481	CcSEcCtD
Remifentanil—Flushing—Bleomycin—melanoma	0.00269	0.00472	CcSEcCtD
Remifentanil—Body temperature increased—Vemurafenib—melanoma	0.00269	0.00472	CcSEcCtD
Remifentanil—Pharyngitis—Dactinomycin—melanoma	0.00269	0.00471	CcSEcCtD
Remifentanil—Chills—Bleomycin—melanoma	0.0026	0.00457	CcSEcCtD
Remifentanil—Haemoglobin—Carmustine—melanoma	0.00255	0.00447	CcSEcCtD
Remifentanil—Haemorrhage—Carmustine—melanoma	0.00253	0.00444	CcSEcCtD
Remifentanil—Erythema—Bleomycin—melanoma	0.00253	0.00443	CcSEcCtD
Remifentanil—Hallucination—Carmustine—melanoma	0.00252	0.00442	CcSEcCtD
Remifentanil—Flushing—Dactinomycin—melanoma	0.00251	0.00441	CcSEcCtD
Remifentanil—Hypersensitivity—Vemurafenib—melanoma	0.00251	0.0044	CcSEcCtD
Remifentanil—Atrial fibrillation—Docetaxel—melanoma	0.00248	0.00436	CcSEcCtD
Remifentanil—Visual disturbance—Docetaxel—melanoma	0.00248	0.00436	CcSEcCtD
Remifentanil—Renal impairment—Docetaxel—melanoma	0.00247	0.00434	CcSEcCtD
Remifentanil—Haemoglobin—Temozolomide—melanoma	0.00246	0.00432	CcSEcCtD
Remifentanil—Haemorrhage—Temozolomide—melanoma	0.00245	0.00429	CcSEcCtD
Remifentanil—Visual impairment—Carmustine—melanoma	0.00244	0.00428	CcSEcCtD
Remifentanil—Hallucination—Temozolomide—melanoma	0.00244	0.00427	CcSEcCtD
Remifentanil—Pharyngitis—Temozolomide—melanoma	0.00243	0.00426	CcSEcCtD
Remifentanil—Chills—Dactinomycin—melanoma	0.00243	0.00426	CcSEcCtD
Remifentanil—Pruritus—Vemurafenib—melanoma	0.00241	0.00422	CcSEcCtD
Remifentanil—Visual impairment—Temozolomide—melanoma	0.00236	0.00414	CcSEcCtD
Remifentanil—Erythema—Dactinomycin—melanoma	0.00236	0.00413	CcSEcCtD
Remifentanil—Flushing—Carmustine—melanoma	0.00235	0.00412	CcSEcCtD
Remifentanil—Anaemia—Bleomycin—melanoma	0.00234	0.0041	CcSEcCtD
Remifentanil—Diarrhoea—Vemurafenib—melanoma	0.00233	0.00408	CcSEcCtD
Remifentanil—Cardiac disorder—Temozolomide—melanoma	0.00227	0.00399	CcSEcCtD
Remifentanil—Flushing—Temozolomide—melanoma	0.00227	0.00399	CcSEcCtD
Remifentanil—Arrhythmia—Carmustine—melanoma	0.00226	0.00397	CcSEcCtD
Remifentanil—Dizziness—Vemurafenib—melanoma	0.00225	0.00395	CcSEcCtD
Remifentanil—Angiopathy—Temozolomide—melanoma	0.00222	0.0039	CcSEcCtD
Remifentanil—Immune system disorder—Temozolomide—melanoma	0.00221	0.00388	CcSEcCtD
Remifentanil—Mediastinal disorder—Temozolomide—melanoma	0.00221	0.00387	CcSEcCtD
Remifentanil—Erythema—Carmustine—melanoma	0.00221	0.00387	CcSEcCtD
Remifentanil—Cough—Bleomycin—melanoma	0.00221	0.00387	CcSEcCtD
Remifentanil—Chills—Temozolomide—melanoma	0.0022	0.00385	CcSEcCtD
Remifentanil—Anaemia—Dactinomycin—melanoma	0.00218	0.00382	CcSEcCtD
Remifentanil—Vomiting—Vemurafenib—melanoma	0.00216	0.0038	CcSEcCtD
Remifentanil—Rash—Vemurafenib—melanoma	0.00215	0.00376	CcSEcCtD
Remifentanil—Dermatitis—Vemurafenib—melanoma	0.00214	0.00376	CcSEcCtD
Remifentanil—Headache—Vemurafenib—melanoma	0.00213	0.00374	CcSEcCtD
Remifentanil—Erythema—Temozolomide—melanoma	0.00213	0.00374	CcSEcCtD
Remifentanil—Nasopharyngitis—Docetaxel—melanoma	0.00211	0.00369	CcSEcCtD
Remifentanil—Confusional state—Bleomycin—melanoma	0.00208	0.00365	CcSEcCtD
Remifentanil—Tremor—Carmustine—melanoma	0.00207	0.00362	CcSEcCtD
Remifentanil—Oedema—Bleomycin—melanoma	0.00206	0.00362	CcSEcCtD
Remifentanil—Anaphylactic shock—Bleomycin—melanoma	0.00206	0.00362	CcSEcCtD
Remifentanil—Anaemia—Carmustine—melanoma	0.00204	0.00358	CcSEcCtD
Remifentanil—Dysphagia—Docetaxel—melanoma	0.00203	0.00357	CcSEcCtD
Remifentanil—Agitation—Carmustine—melanoma	0.00203	0.00355	CcSEcCtD
Remifentanil—Nausea—Vemurafenib—melanoma	0.00202	0.00355	CcSEcCtD
Remifentanil—Thrombocytopenia—Bleomycin—melanoma	0.00202	0.00354	CcSEcCtD
Remifentanil—Bronchospasm—Docetaxel—melanoma	0.002	0.00351	CcSEcCtD
Remifentanil—Tremor—Temozolomide—melanoma	0.002	0.0035	CcSEcCtD
Remifentanil—Anaemia—Temozolomide—melanoma	0.00197	0.00345	CcSEcCtD
Remifentanil—Agitation—Temozolomide—melanoma	0.00196	0.00344	CcSEcCtD
Remifentanil—Hypotension—Bleomycin—melanoma	0.00193	0.00338	CcSEcCtD
Remifentanil—Oedema—Dactinomycin—melanoma	0.00192	0.00337	CcSEcCtD
Remifentanil—Convulsion—Carmustine—melanoma	0.00191	0.00335	CcSEcCtD
Remifentanil—Hypertension—Carmustine—melanoma	0.0019	0.00334	CcSEcCtD
Remifentanil—Thrombocytopenia—Dactinomycin—melanoma	0.00188	0.0033	CcSEcCtD
Remifentanil—Anxiety—Carmustine—melanoma	0.00187	0.00328	CcSEcCtD
Remifentanil—Cough—Temozolomide—melanoma	0.00186	0.00326	CcSEcCtD
Remifentanil—Paraesthesia—Bleomycin—melanoma	0.00185	0.00325	CcSEcCtD
Remifentanil—Convulsion—Temozolomide—melanoma	0.00185	0.00324	CcSEcCtD
Remifentanil—Hypertension—Temozolomide—melanoma	0.00184	0.00323	CcSEcCtD
Remifentanil—Dyspnoea—Bleomycin—melanoma	0.00184	0.00322	CcSEcCtD
Remifentanil—Pneumonia—Docetaxel—melanoma	0.00182	0.0032	CcSEcCtD
Remifentanil—Confusional state—Carmustine—melanoma	0.00182	0.00318	CcSEcCtD
Remifentanil—Anxiety—Temozolomide—melanoma	0.00181	0.00317	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.0018	0.00316	CcSEcCtD
Remifentanil—Oedema—Carmustine—melanoma	0.0018	0.00316	CcSEcCtD
Remifentanil—Renal failure—Docetaxel—melanoma	0.00178	0.00313	CcSEcCtD
Remifentanil—Dry mouth—Temozolomide—melanoma	0.00177	0.00311	CcSEcCtD
Remifentanil—Pain—Bleomycin—melanoma	0.00176	0.00309	CcSEcCtD
Remifentanil—Thrombocytopenia—Carmustine—melanoma	0.00176	0.00309	CcSEcCtD
Remifentanil—Tachycardia—Carmustine—melanoma	0.00176	0.00308	CcSEcCtD
Remifentanil—Confusional state—Temozolomide—melanoma	0.00175	0.00308	CcSEcCtD
Remifentanil—Oedema—Temozolomide—melanoma	0.00174	0.00305	CcSEcCtD
Remifentanil—Anaphylactic shock—Temozolomide—melanoma	0.00174	0.00305	CcSEcCtD
Remifentanil—Nervous system disorder—Temozolomide—melanoma	0.00171	0.00299	CcSEcCtD
Remifentanil—Thrombocytopenia—Temozolomide—melanoma	0.0017	0.00299	CcSEcCtD
Remifentanil—Feeling abnormal—Bleomycin—melanoma	0.0017	0.00298	CcSEcCtD
Remifentanil—Skin disorder—Temozolomide—melanoma	0.00169	0.00296	CcSEcCtD
Remifentanil—Hypotension—Carmustine—melanoma	0.00168	0.00295	CcSEcCtD
Remifentanil—Hyperhidrosis—Temozolomide—melanoma	0.00168	0.00295	CcSEcCtD
Remifentanil—Pain—Dactinomycin—melanoma	0.00164	0.00288	CcSEcCtD
Remifentanil—Urticaria—Bleomycin—melanoma	0.00164	0.00287	CcSEcCtD
Remifentanil—Haemoglobin—Docetaxel—melanoma	0.00164	0.00287	CcSEcCtD
Remifentanil—Body temperature increased—Bleomycin—melanoma	0.00163	0.00286	CcSEcCtD
Remifentanil—Haemorrhage—Docetaxel—melanoma	0.00163	0.00286	CcSEcCtD
Remifentanil—Paraesthesia—Carmustine—melanoma	0.00162	0.00283	CcSEcCtD
Remifentanil—Pharyngitis—Docetaxel—melanoma	0.00162	0.00283	CcSEcCtD
Remifentanil—Dyspnoea—Carmustine—melanoma	0.00161	0.00281	CcSEcCtD
Remifentanil—Somnolence—Carmustine—melanoma	0.0016	0.00281	CcSEcCtD
Remifentanil—Feeling abnormal—Dactinomycin—melanoma	0.00159	0.00278	CcSEcCtD
Remifentanil—Visual impairment—Docetaxel—melanoma	0.00157	0.00275	CcSEcCtD
Remifentanil—Paraesthesia—Temozolomide—melanoma	0.00156	0.00274	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Carmustine—melanoma	0.00155	0.00273	CcSEcCtD
Remifentanil—Dyspnoea—Temozolomide—melanoma	0.00155	0.00272	CcSEcCtD
Remifentanil—Somnolence—Temozolomide—melanoma	0.00155	0.00271	CcSEcCtD
Remifentanil—Pain—Carmustine—melanoma	0.00154	0.0027	CcSEcCtD
Remifentanil—Constipation—Carmustine—melanoma	0.00154	0.0027	CcSEcCtD
Remifentanil—Dyspepsia—Temozolomide—melanoma	0.00153	0.00269	CcSEcCtD
Remifentanil—Body temperature increased—Dactinomycin—melanoma	0.00152	0.00267	CcSEcCtD
Remifentanil—Hypersensitivity—Bleomycin—melanoma	0.00152	0.00266	CcSEcCtD
Remifentanil—Pethidine—ALB—melanoma	0.00151	0.0804	CrCbGaD
Remifentanil—Flushing—Docetaxel—melanoma	0.00151	0.00265	CcSEcCtD
Remifentanil—Cardiac disorder—Docetaxel—melanoma	0.00151	0.00265	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Temozolomide—melanoma	0.0015	0.00263	CcSEcCtD
Remifentanil—Constipation—Temozolomide—melanoma	0.00149	0.00261	CcSEcCtD
Remifentanil—Pain—Temozolomide—melanoma	0.00149	0.00261	CcSEcCtD
Remifentanil—Feeling abnormal—Carmustine—melanoma	0.00148	0.0026	CcSEcCtD
Remifentanil—Angiopathy—Docetaxel—melanoma	0.00148	0.00259	CcSEcCtD
Remifentanil—Immune system disorder—Docetaxel—melanoma	0.00147	0.00258	CcSEcCtD
Remifentanil—Mediastinal disorder—Docetaxel—melanoma	0.00147	0.00257	CcSEcCtD
Remifentanil—Chills—Docetaxel—melanoma	0.00146	0.00256	CcSEcCtD
Remifentanil—Pruritus—Bleomycin—melanoma	0.00146	0.00256	CcSEcCtD
Remifentanil—Arrhythmia—Docetaxel—melanoma	0.00145	0.00255	CcSEcCtD
Remifentanil—Feeling abnormal—Temozolomide—melanoma	0.00143	0.00251	CcSEcCtD
Remifentanil—Body temperature increased—Carmustine—melanoma	0.00142	0.0025	CcSEcCtD
Remifentanil—Erythema—Docetaxel—melanoma	0.00142	0.00249	CcSEcCtD
Remifentanil—Hypersensitivity—Dactinomycin—melanoma	0.00142	0.00249	CcSEcCtD
Remifentanil—Urticaria—Temozolomide—melanoma	0.00138	0.00242	CcSEcCtD
Remifentanil—Body temperature increased—Temozolomide—melanoma	0.00138	0.00241	CcSEcCtD
Remifentanil—Hypersensitivity—Carmustine—melanoma	0.00133	0.00233	CcSEcCtD
Remifentanil—Diarrhoea—Dactinomycin—melanoma	0.00132	0.00231	CcSEcCtD
Remifentanil—Vomiting—Bleomycin—melanoma	0.00131	0.0023	CcSEcCtD
Remifentanil—Anaemia—Docetaxel—melanoma	0.00131	0.0023	CcSEcCtD
Remifentanil—Rash—Bleomycin—melanoma	0.0013	0.00228	CcSEcCtD
Remifentanil—Dermatitis—Bleomycin—melanoma	0.0013	0.00228	CcSEcCtD
Remifentanil—Hypersensitivity—Temozolomide—melanoma	0.00128	0.00225	CcSEcCtD
Remifentanil—Syncope—Docetaxel—melanoma	0.00127	0.00223	CcSEcCtD
Remifentanil—Loss of consciousness—Docetaxel—melanoma	0.00125	0.00218	CcSEcCtD
Remifentanil—Cough—Docetaxel—melanoma	0.00124	0.00217	CcSEcCtD
Remifentanil—Diarrhoea—Carmustine—melanoma	0.00123	0.00216	CcSEcCtD
Remifentanil—Pruritus—Temozolomide—melanoma	0.00123	0.00216	CcSEcCtD
Remifentanil—Convulsion—Docetaxel—melanoma	0.00123	0.00215	CcSEcCtD
Remifentanil—Nausea—Bleomycin—melanoma	0.00123	0.00215	CcSEcCtD
Remifentanil—Hypertension—Docetaxel—melanoma	0.00122	0.00215	CcSEcCtD
Remifentanil—Vomiting—Dactinomycin—melanoma	0.00122	0.00214	CcSEcCtD
Remifentanil—Rash—Dactinomycin—melanoma	0.00121	0.00213	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.0012	0.0021	CcSEcCtD
Remifentanil—Dizziness—Carmustine—melanoma	0.00119	0.00209	CcSEcCtD
Remifentanil—Diarrhoea—Temozolomide—melanoma	0.00119	0.00209	CcSEcCtD
Remifentanil—Dry mouth—Docetaxel—melanoma	0.00118	0.00207	CcSEcCtD
Remifentanil—Fentanyl—ABCB1—melanoma	0.00117	0.0623	CrCbGaD
Remifentanil—Confusional state—Docetaxel—melanoma	0.00117	0.00205	CcSEcCtD
Remifentanil—Oedema—Docetaxel—melanoma	0.00116	0.00203	CcSEcCtD
Remifentanil—Anaphylactic shock—Docetaxel—melanoma	0.00116	0.00203	CcSEcCtD
Remifentanil—Dizziness—Temozolomide—melanoma	0.00115	0.00202	CcSEcCtD
Remifentanil—Vomiting—Carmustine—melanoma	0.00114	0.00201	CcSEcCtD
Remifentanil—Nausea—Dactinomycin—melanoma	0.00114	0.002	CcSEcCtD
Remifentanil—Shock—Docetaxel—melanoma	0.00114	0.002	CcSEcCtD
Remifentanil—Rash—Carmustine—melanoma	0.00114	0.00199	CcSEcCtD
Remifentanil—Nervous system disorder—Docetaxel—melanoma	0.00113	0.00199	CcSEcCtD
Remifentanil—Dermatitis—Carmustine—melanoma	0.00113	0.00199	CcSEcCtD
Remifentanil—Thrombocytopenia—Docetaxel—melanoma	0.00113	0.00199	CcSEcCtD
Remifentanil—Tachycardia—Docetaxel—melanoma	0.00113	0.00198	CcSEcCtD
Remifentanil—Headache—Carmustine—melanoma	0.00113	0.00198	CcSEcCtD
Remifentanil—Skin disorder—Docetaxel—melanoma	0.00112	0.00197	CcSEcCtD
Remifentanil—Vomiting—Temozolomide—melanoma	0.00111	0.00194	CcSEcCtD
Remifentanil—Rash—Temozolomide—melanoma	0.0011	0.00192	CcSEcCtD
Remifentanil—Dermatitis—Temozolomide—melanoma	0.0011	0.00192	CcSEcCtD
Remifentanil—Headache—Temozolomide—melanoma	0.00109	0.00191	CcSEcCtD
Remifentanil—Hypotension—Docetaxel—melanoma	0.00108	0.0019	CcSEcCtD
Remifentanil—Nausea—Carmustine—melanoma	0.00107	0.00188	CcSEcCtD
Remifentanil—Paraesthesia—Docetaxel—melanoma	0.00104	0.00182	CcSEcCtD
Remifentanil—Nausea—Temozolomide—melanoma	0.00103	0.00181	CcSEcCtD
Remifentanil—Dyspnoea—Docetaxel—melanoma	0.00103	0.00181	CcSEcCtD
Remifentanil—Somnolence—Docetaxel—melanoma	0.00103	0.0018	CcSEcCtD
Remifentanil—Dyspepsia—Docetaxel—melanoma	0.00102	0.00179	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Docetaxel—melanoma	0.000999	0.00175	CcSEcCtD
Remifentanil—Pain—Docetaxel—melanoma	0.000989	0.00173	CcSEcCtD
Remifentanil—Constipation—Docetaxel—melanoma	0.000989	0.00173	CcSEcCtD
Remifentanil—Feeling abnormal—Docetaxel—melanoma	0.000953	0.00167	CcSEcCtD
Remifentanil—Body temperature increased—Docetaxel—melanoma	0.000915	0.0016	CcSEcCtD
Remifentanil—Hypersensitivity—Docetaxel—melanoma	0.000852	0.00149	CcSEcCtD
Remifentanil—Pruritus—Docetaxel—melanoma	0.000819	0.00144	CcSEcCtD
Remifentanil—Diarrhoea—Docetaxel—melanoma	0.000792	0.00139	CcSEcCtD
Remifentanil—Dizziness—Docetaxel—melanoma	0.000765	0.00134	CcSEcCtD
Remifentanil—Vomiting—Docetaxel—melanoma	0.000736	0.00129	CcSEcCtD
Remifentanil—Rash—Docetaxel—melanoma	0.00073	0.00128	CcSEcCtD
Remifentanil—Dermatitis—Docetaxel—melanoma	0.000729	0.00128	CcSEcCtD
Remifentanil—Headache—Docetaxel—melanoma	0.000725	0.00127	CcSEcCtD
Remifentanil—Nausea—Docetaxel—melanoma	0.000687	0.00121	CcSEcCtD
Remifentanil—OPRK1—Signaling Pathways—GNAQ—melanoma	0.000162	0.000394	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—F2R—melanoma	0.000161	0.000392	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SOCS1—melanoma	0.000158	0.000384	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAP2K1—melanoma	0.000157	0.000383	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—S100B—melanoma	0.000157	0.000383	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CD—melanoma	0.000156	0.00038	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RAC1—melanoma	0.000156	0.00038	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CG—melanoma	0.000156	0.000379	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDNRB—melanoma	0.000156	0.000379	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SYK—melanoma	0.000152	0.00037	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTK2B—melanoma	0.000151	0.000368	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CD—melanoma	0.000151	0.000367	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB4—melanoma	0.00015	0.000366	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CB—melanoma	0.00015	0.000365	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ITGAV—melanoma	0.000149	0.000364	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NGFR—melanoma	0.000149	0.000364	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT3—melanoma	0.000149	0.000364	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN2B—melanoma	0.000149	0.000363	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GAB2—melanoma	0.000147	0.000358	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNA11—melanoma	0.000147	0.000358	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FLT1—melanoma	0.000146	0.000357	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CG—melanoma	0.000145	0.000353	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD86—melanoma	0.000144	0.000351	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—CXCL8—melanoma	0.000144	0.000351	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EDN1—melanoma	0.000143	0.000348	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CSF2—melanoma	0.00014	0.00034	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF1—melanoma	0.00014	0.00034	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR4—melanoma	0.000138	0.000337	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HDAC2—melanoma	0.000138	0.000337	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FOXO4—melanoma	0.000138	0.000337	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SOCS1—melanoma	0.000138	0.000337	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAP2K1—melanoma	0.000138	0.000336	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—S100B—melanoma	0.000138	0.000336	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2—melanoma	0.000138	0.000335	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CD—melanoma	0.000137	0.000334	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—E2F1—melanoma	0.000137	0.000333	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNAQ—melanoma	0.000137	0.000333	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CB—melanoma	0.000136	0.000332	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDGFRA—melanoma	0.000135	0.00033	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ITGB3—melanoma	0.000134	0.000326	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCA—melanoma	0.000134	0.000326	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB4—melanoma	0.000132	0.000321	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CG—melanoma	0.000132	0.000321	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CB—melanoma	0.000132	0.00032	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SPP1—melanoma	0.000132	0.00032	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAP2K2—melanoma	0.000131	0.000319	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CXCL8—melanoma	0.000131	0.000319	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN2B—melanoma	0.000131	0.000318	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SYK—melanoma	0.000129	0.000313	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CD—melanoma	0.000128	0.00031	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD86—melanoma	0.000126	0.000308	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—CXCL8—melanoma	0.000126	0.000308	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NGFR—melanoma	0.000126	0.000307	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ITGAV—melanoma	0.000126	0.000307	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT3—melanoma	0.000126	0.000307	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EDN1—melanoma	0.000125	0.000305	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—melanoma	0.000125	0.000305	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TERT—melanoma	0.000125	0.000303	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RAC1—melanoma	0.000124	0.000303	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF1—melanoma	0.000123	0.000299	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CSF2—melanoma	0.000123	0.000299	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—melanoma	0.000121	0.000294	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—E2F1—melanoma	0.00012	0.000292	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CB—melanoma	0.000119	0.000291	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HIF1A—melanoma	0.000119	0.00029	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDGFRA—melanoma	0.000119	0.000289	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCA—melanoma	0.000118	0.000286	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ITGB3—melanoma	0.000118	0.000286	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SOCS1—melanoma	0.000117	0.000284	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAP2K1—melanoma	0.000117	0.000284	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—S100B—melanoma	0.000117	0.000284	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CD—melanoma	0.000116	0.000282	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SPP1—melanoma	0.000115	0.000281	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAP2K2—melanoma	0.000115	0.00028	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CXCL8—melanoma	0.000115	0.000279	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KDR—melanoma	0.000114	0.000278	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB4—melanoma	0.000111	0.000271	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	0.000111	0.000271	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN2B—melanoma	0.000111	0.000269	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FN1—melanoma	0.00011	0.000267	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—melanoma	0.00011	0.000267	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TERT—melanoma	0.000109	0.000266	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RAC1—melanoma	0.000109	0.000265	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH1—melanoma	0.000107	0.000261	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD86—melanoma	0.000107	0.00026	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—CXCL8—melanoma	0.000107	0.00026	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EDN1—melanoma	0.000106	0.000258	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD80—melanoma	0.000105	0.000256	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CG—melanoma	0.000105	0.000256	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APC—melanoma	0.000105	0.000256	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KIT—melanoma	0.000105	0.000256	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—NRAS—melanoma	0.000105	0.000256	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HIF1A—melanoma	0.000105	0.000254	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGF—melanoma	0.000104	0.000253	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF1—melanoma	0.000104	0.000252	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CSF2—melanoma	0.000104	0.000252	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—melanoma	0.000102	0.000249	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—E2F1—melanoma	0.000101	0.000247	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CB—melanoma	0.000101	0.000246	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK3—melanoma	0.000101	0.000245	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFRA—melanoma	0.0001	0.000244	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KDR—melanoma	0.0001	0.000243	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCA—melanoma	9.94e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ITGB3—melanoma	9.94e-05	0.000242	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BRAF—melanoma	9.87e-05	0.00024	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SPP1—melanoma	9.75e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAP2K2—melanoma	9.72e-05	0.000236	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CXCL8—melanoma	9.7e-05	0.000236	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FN1—melanoma	9.62e-05	0.000234	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—melanoma	9.62e-05	0.000234	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK1—melanoma	9.57e-05	0.000233	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—EGFR—melanoma	9.57e-05	0.000233	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH1—melanoma	9.42e-05	0.000229	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAP2K1—melanoma	9.3e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—melanoma	9.27e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TERT—melanoma	9.24e-05	0.000225	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CD—melanoma	9.23e-05	0.000225	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD80—melanoma	9.23e-05	0.000225	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RAC1—melanoma	9.21e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APC—melanoma	9.21e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CG—melanoma	9.21e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KIT—melanoma	9.21e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—NRAS—melanoma	9.21e-05	0.000224	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	9.15e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGF—melanoma	9.1e-05	0.000222	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—KRAS—melanoma	9.04e-05	0.00022	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF2—melanoma	8.84e-05	0.000215	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HIF1A—melanoma	8.84e-05	0.000215	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK3—melanoma	8.82e-05	0.000215	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BRAF—melanoma	8.66e-05	0.000211	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KDR—melanoma	8.45e-05	0.000206	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—melanoma	8.43e-05	0.000205	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK1—melanoma	8.39e-05	0.000204	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—EGFR—melanoma	8.39e-05	0.000204	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—melanoma	8.31e-05	0.000202	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MDM2—melanoma	8.27e-05	0.000201	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ERBB2—melanoma	8.16e-05	0.000198	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAP2K1—melanoma	8.15e-05	0.000198	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FN1—melanoma	8.13e-05	0.000198	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CD—melanoma	8.1e-05	0.000197	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CB—melanoma	8.05e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	8.02e-05	0.000195	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH1—melanoma	7.96e-05	0.000194	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—KRAS—melanoma	7.93e-05	0.000193	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD80—melanoma	7.8e-05	0.00019	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APC—melanoma	7.78e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CG—melanoma	7.78e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KIT—melanoma	7.78e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—NRAS—melanoma	7.78e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF2—melanoma	7.75e-05	0.000189	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CXCL8—melanoma	7.73e-05	0.000188	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGF—melanoma	7.69e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HRAS—melanoma	7.68e-05	0.000187	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1B—melanoma	7.55e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—melanoma	7.47e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK3—melanoma	7.45e-05	0.000181	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—melanoma	7.4e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—melanoma	7.39e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—melanoma	7.35e-05	0.000179	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BRAF—melanoma	7.32e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—melanoma	7.28e-05	0.000177	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MDM2—melanoma	7.25e-05	0.000177	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCND1—melanoma	7.21e-05	0.000175	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ERBB2—melanoma	7.15e-05	0.000174	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CTNNB1—melanoma	7.14e-05	0.000174	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—melanoma	7.13e-05	0.000173	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK1—melanoma	7.09e-05	0.000173	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—EGFR—melanoma	7.09e-05	0.000173	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CB—melanoma	7.06e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—melanoma	7e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1A—melanoma	6.97e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTEN—melanoma	6.95e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKB1—melanoma	6.92e-05	0.000168	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAP2K1—melanoma	6.89e-05	0.000168	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CD—melanoma	6.84e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—melanoma	6.78e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CXCL8—melanoma	6.78e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	6.78e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HRAS—melanoma	6.74e-05	0.000164	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KRAS—melanoma	6.7e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1B—melanoma	6.62e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF2—melanoma	6.55e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—melanoma	6.55e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—melanoma	6.49e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—melanoma	6.48e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—melanoma	6.45e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCND1—melanoma	6.32e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—melanoma	6.28e-05	0.000153	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CTNNB1—melanoma	6.26e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—melanoma	6.22e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NRAS—melanoma	6.2e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—melanoma	6.16e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—melanoma	6.13e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MDM2—melanoma	6.13e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1A—melanoma	6.11e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTEN—melanoma	6.1e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKB1—melanoma	6.07e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ERBB2—melanoma	6.04e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CB—melanoma	5.96e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—melanoma	5.95e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK3—melanoma	5.94e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—melanoma	5.78e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCL8—melanoma	5.73e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HRAS—melanoma	5.69e-05	0.000139	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK1—melanoma	5.65e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EGFR—melanoma	5.65e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1B—melanoma	5.6e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—melanoma	5.54e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—melanoma	5.51e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—melanoma	5.49e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—melanoma	5.48e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—melanoma	5.45e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—melanoma	5.45e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NRAS—melanoma	5.44e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KRAS—melanoma	5.34e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCND1—melanoma	5.34e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CTNNB1—melanoma	5.29e-05	0.000129	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK3—melanoma	5.21e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—melanoma	5.18e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1A—melanoma	5.17e-05	0.000126	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTEN—melanoma	5.15e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKB1—melanoma	5.13e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—melanoma	5.07e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—melanoma	5.03e-05	0.000122	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK1—melanoma	4.96e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EGFR—melanoma	4.96e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—melanoma	4.91e-05	0.000119	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—melanoma	4.75e-05	0.000116	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KRAS—melanoma	4.68e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—melanoma	4.66e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—melanoma	4.61e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NRAS—melanoma	4.6e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HRAS—melanoma	4.54e-05	0.00011	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK3—melanoma	4.4e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—melanoma	4.34e-05	0.000106	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—melanoma	4.3e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—melanoma	4.28e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK1—melanoma	4.19e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EGFR—melanoma	4.19e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—melanoma	4.16e-05	0.000101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—melanoma	4.01e-05	9.76e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HRAS—melanoma	3.98e-05	9.69e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KRAS—melanoma	3.96e-05	9.63e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—melanoma	3.81e-05	9.27e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—melanoma	3.64e-05	8.85e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—melanoma	3.52e-05	8.56e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—melanoma	3.51e-05	8.55e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HRAS—melanoma	3.36e-05	8.19e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—melanoma	3.22e-05	7.84e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—melanoma	2.97e-05	7.23e-05	CbGpPWpGaD
